We develop a class of polymer–inorganic hybrid microgels, comprising Ag nanoparticle cores covered by a poly(3-acrylamidophenylboronic acid-co-2-(dimethylamino)ethyl acrylate) [p(3-VAPBA-co-DMAEA)] gel shell, to demonstrate that the volume phase transition behaviour of poly(phenylboronic acid) gels can be tailored from exhibiting monotonous swelling to monotonous shrinking upon adding glucose at a physiological pH of 7.4, via varying the feeding ratio of monomers DMAEA (introducing positive charges by ionization) to 3-VAPBA (introducing negative charges through the formation of a glucose–boronate complex) in the synthesis. The counterbalance of the positive and negative charges at particular glucose concentrations is a key parameter to enable this tailoring. Accompanied by this tailoring, the photoluminescence of the hybrid microgels is tuned from glucose-responsive “turn-off” to “turn-on”, in which the latter displays an improved glucose-sensing performance in both artificial tear fluid (a model for low glucose concentrations) and urine (for high glucose concentrations).
No takes yet. Share an insight, caveat, or question.
Ye et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: